Cargando…
Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
A slow rate of new drug discovery and higher costs of new drug development attracted the attention of scientists and physicians for the repurposing and repositioning of old medications. Experimental studies and off-label use of drugs have helped drive data for further studies of approving these medi...
Autores principales: | Mohammad Sadeghi, Hosna, Adeli, Ida, Mousavi, Taraneh, Daniali, Marzieh, Nikfar, Shekoufeh, Abdollahi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8398872/ https://www.ncbi.nlm.nih.gov/pubmed/34440518 http://dx.doi.org/10.3390/life11080774 |
Ejemplares similares
-
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
por: Sadeghi, Hosna Mohammad, et al.
Publicado: (2022) -
Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter
por: Mousavi, Taraneh, et al.
Publicado: (2021) -
Where Do We Stand?
Publicado: (1891) -
Gravity: where do we stand ?
por: Peron, Roberto, et al.
Publicado: (2016) -
Late Sodium Current of the Heart: Where Do We Stand and Where Are We Going?
por: Horváth, Balázs, et al.
Publicado: (2022)